List | Section | Observation |
---|---|---|
Peru | 8.2 Cytotoxics | No observations |
Cuba | 8.3.1 Anticuerpos monoclonales | No observations |
WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
Others observations: Including quality-assured biosimilars − Diffuse large B-cell lymphoma − Chronic lymphocytic leukaemia − Follicular lymphoma |
List | Section | Observation |
---|---|---|
Peru | 8.2 Cytotoxics | No observations |
Cuba | 8.3.1 Anticuerpos monoclonales | No observations |
WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
Others observations: Including quality-assured biosimilars − Diffuse large B-cell lymphoma − Chronic lymphocytic leukaemia − Follicular lymphoma |
List | Section | Observation |
---|---|---|
Ecuador | Essential Medicines List - Ecuador | No observations |